CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Returned to the company President & C.E.O. returned 18,295 shares (to the company)
- 4 Returned to the company President, MGL returned 6,653 shares (to the company)
- 4 Returned to the company Chief Scientific Officer returned 5,544 shares (to the company)
- 4 Returned to the company E.V.P., General Counsel returned 5,544 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 6,653 shares (to the company)
- 4 Returned to the company President Assurex Health Inc. returned 2,897 shares (to the company)
- 4 Returned to the company Exec. VP International Ops returned 3,327 shares (to the company)
- 4 Returned to the company President Crescendo BioScience returned 4,958 shares (to the company)
- 4 Returned to the company President Myriad Oncology returned 1,664 shares (to the company)
- 4 Returned to the company President Myriad RBM, Inc. returned 2,952 shares (to the company)
- 4 Grant or award President Myriad RBM, Inc. acquired 27,000 shares (grant or award)
- 4 Grant or award President Crescendo BioScience acquired 35,000 shares (grant or award)
- 4 Grant or award Exec. VP International Ops acquired 27,000 shares (grant or award)
- 4 Grant or award President Assurex Health Inc. acquired 40,000 shares (grant or award)
- 4 Grant or award President, MGL acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 50,000 shares (grant or award)
- 4 Grant or award E.V.P., General Counsel acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award President & C.E.O. acquired 165,000 shares (grant or award)
- 4 Returned to the company Chief Scientific Officer returned 6,515 shares (to the company)
Page 26 of 65 · 1,294 filings